Toremfine is a selective estrogen receptor peptide. It is sometimes referred to as Toremifene citrate or Fareston. It contains a molecular weight of 598.08. It is available for purchase of the expressed, exclusive use of scientific study and research on animal test subjects. It is clear in its appearance, and is liquid in its physical state.
Mechanics of Toremifene
Scientific study on animal test subjects has determined that Toremifene is a selective estrogen receptor. What this means is, it is a peptide that acts upon estrogen receptors in the body of animal test subjects, which are protein groups that are activated by estrogen for the purposes of creating a secretion. The peptide bonds with estrogen receptors that are found in the breast tissue of animal test subjects. This bond results in the blocking of the receptors in their production of estrogen from the cells located in the breast tissue. In turn, this inhibition of estrogen receptors and subsequently their secretions leads to a more regulated and controlled amount of secretions being produced by this part of the body on animal test subjects.
Theoretical Benefits of Toremifene
Scientific research that has been conducted on animal test subjects in relation to Toremifene has determined that the peptide could provide several theoretical benefits.
The primary focus on such scientific research is concentrated on Toremifene’s association with the treatment of breast cancer. Certain types of breast cancers have been tied to the functionality of the endocrine system; the bodily system that controls and regulates the secretions of natural chemicals that provide the body with the resources needed for proper development, functionality, and a sense of proper homeostasis. In these cases, the cancer has been determined to be caused due to a proliferation of cancer cells stemming from the production of estrogen in the breast tissue. Because Toremifene has been shown to be an inhibitor of estrogen secretion based on scientific study of animal test subjects, it is theorized that the associated blockage can be linked to slowing down the proliferation of cancerous cells that are created through the secretion of estrogen. This, in turn, would enable for a more improved treatment of cancers generating from breast tissue. Furthermore, this inhibition of estrogen secretion would also allow for the inhibition of metastatic breast cancer; that is, breast cancer that proliferates and spreads into other parts of an animal test subject’s body.
Additional scientific study based on animal test subject has determined that the peptide’s ability as an androgen inhibitor may have a theoretical benefit in the treatment of other cancers that are tied to the endocrine system, such as prostate cancer.
Other serious negative side effects in relation to Toremifiene have been determined through scientific study on animal test subjects. Some of these serious negative side effects include:
- Vaginal bleeding
- Unusual vaginal discharge
- Irregularity of periods
- Pelvic pain or pressure
- Muscle pain
- Muscle weakness
- Frequent urination
- Pain in abdomen
- Pain in joints
- Loss of appetite
- Excessive thirst
Other less serious side effects relating to Toremifine include:
- Blurred vision
- Sensitivity to light
- Abnormal vision
- Night blindness
- Swelling of feet, ankles, lower legs, and hands
Potential Negative Side Effects of Toremifene
Even though scientific research that has been conducted on animal test subjects has determined several theoretical benefits in relation to Toremifene, it should be noted that there have also been a few potential negative side effects that have been associated with the peptide.
The most serious negative side effect that has been hypotehsized through scientific study on animal test subjects have been related to the development of cancer of the endometrium; that is, the lining of the uterus. That said, scientific research on animal test subjects has yet to officially determine whether or not a definitive link between Toremifene and this type of cancer exists.
For Scientific Use Only
Although there have been several scientific studies conducted on animal test subjects in order to determine Toremifene’s range of mechanics, theoretical benefits, and negative side effects, it should be noted that any findings that are associated with the peptide are still considered to be the product of current laboratory research conducted on animal test subjects. Because Toremifene is currently in the research phase, any matters of purchase relating to this peptide must exclusively be contained to scientific research and study and must be contained to the restrictions of a strictly controlled environment such as a laboratory or a medical research facility.